LGND
Ligand Pharmaceuticals Inc
Price:  
84.91 
USD
Volume:  
125,663.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND EV/EBITDA

-48.5%
Upside

As of 2024-05-24, the EV/EBITDA ratio of Ligand Pharmaceuticals Inc (LGND) is 45.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LGND's latest enterprise value is 1,474.89 mil USD. LGND's TTM EBITDA according to its financial statements is 32.55 mil USD. Dividing these 2 quantities gives us the above LGND EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 21.0x - 24.8x 24.6x
Forward P/E multiples 22.2x - 29.0x 23.2x
Fair Price 38.52 - 49.44 43.77
Upside -54.6% - -41.8% -48.5%
84.91 USD
Stock Price
43.77 USD
Fair Price

LGND EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 45.32
2024-05-22 46.63
2024-05-21 46.47
2024-05-20 46.27
2024-05-17 45.95
2024-05-16 45.38
2024-05-15 45.79
2024-05-14 45.53
2024-05-13 44.85
2024-05-10 46.63
2024-05-09 45.99
2024-05-08 42.81
2024-05-07 38.87
2024-05-06 38.65
2024-05-03 39.24
2024-05-02 38.37
2024-05-01 37.87
2024-04-30 37.03
2024-04-29 37.34
2024-04-26 37.40
2024-04-25 37.29
2024-04-24 37.64
2024-04-23 37.03
2024-04-22 36.28
2024-04-19 38.45
2024-04-18 38.48
2024-04-17 41.98
2024-04-16 42.56
2024-04-15 42.48
2024-04-12 43.36
2024-04-11 43.40
2024-04-10 43.04
2024-04-09 43.44
2024-04-08 42.39
2024-04-05 41.48
2024-04-04 41.49
2024-04-03 39.70
2024-04-02 38.86
2024-04-01 39.08
2024-03-28 38.80
2024-03-27 37.79
2024-03-26 36.34
2024-03-25 36.68
2024-03-22 37.64
2024-03-21 38.72
2024-03-20 38.81
2024-03-19 38.31
2024-03-18 38.27
2024-03-15 37.69
2024-03-14 38.15